Form 4 for NVAX NOVAVAX INC
Accepted 2024-03-12 00:00:00 ET · period of report 2024-03-10 · accession 0001104659-24-033619 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-12 | 2024-03-10 | NVAX | Trizzino John | Pres, COO | M - OptEx | — | +4,608 | 30.2K | +18% | — |
| D | 2024-03-12 | 2024-03-10 | NVAX | Trizzino John | Pres, COO | F - Tax | $5.45 | -2,226 | 28.0K | -7% | -$12.1K |
| D | 2024-03-12 | 2024-03-10 | NVAX | Trizzino John | Pres, COO | M - OptEx | $0.00 | -4,608 | 4,608 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-10 | M | A | 4,608 | — | 30,198 | D | — | — | (F1) Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. |
| 2 | Common | Common Stock | 2024-03-10 | F | D | 2,226 | $5.45 | 27,972 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2024-03-10 | M | D | 4,608 | $0.00 | 4,608 | D | — · — to — | 4,608 Common Stock | (F1) Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. (F2) One-third (1/3) of the RSUs subject to this grant under the Amended and Restated 2015 Stock Incentive Plan will vest on each of the first three (3) anniversaries of March 10, 2022, the Grant Date, in each case subject to continued employment through such vesting date. |